• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Carlyle acquires AkzoNobel's chemicals arm in €10bn deal

  • Francesca Veronesi
  • Francesca Veronesi
  • 27 March 2018
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

The Carlyle Group and the Government of Singapore Investment Corporation (GIC) have wholly acquired AkzoNobel Specialty Chemicals, the chemicals arm of Dutch giant AkzoNobel, in a €10.1bn transaction.

On the basis of its year-end balance sheet, AkzoNobel expects to receive a cash payment of €8.9bn. Following deduction of deal- and separation-related costs, as well as other previously announced liabilities, the net proceeds are expected to be around €7.5bn.

The GP will use two vehicles for the transaction – Carlyle Partners VII and Carlyle Europe Partners IV. Carlyle Partners VII, announced in June 2017, has a target of $15bn and its hard-cap was set at $18.5bn. An interim close was held in March 2018 on $15.57bn, according to Unquote Data. The vehicle was originally meant for North American deals.

AkzoNobel Specialty Chemicals

  • DEAL:

    Buyout

  • VALUE:

    €10.1bn

  • LOCATION:

    Amsterdam

  • SECTOR:

    Speciality chemicals

  • FOUNDED:

    1994

  • TURNOVER:

    €5bn

  • STAFF:

    12,000

Carlyle Europe Partners IV held a final close on July 2015 on €3.75bn, reaching the vehicle's hard-cap. The fund was meant to target European upper-mid-market companies across a wide range of sectors. According to Unquote Data, it was deployed at 72% before this transaction.

GIC is one of the three reserve management entities in Singapore, alongside the Monetary Authority of Singapore and Temasek.

A spokesperson for Carlyle confirmed the transaction will see co-investors backing the deal alongside Carlyle and GIC. The transaction is expected to be completed before the end of 2018.

AkzoNobel's management and supervisory boards were initially considering the options of either listing the divisions via a de-merger or selling to a private backer.

In February, news reports emerged that several bidders were competing against Carlyle, including a partnership between Advent and Bain; Apollo, joined by German speciality chemicals producer Lanxess; and Hal Investments, according to the Financial Times. Later on in the month, Apollo was said to have chosen to team up with one of the largest Dutch pension funds, PGGM.

AkzoNobel's paints, coatings and speciality chemicals divisions will now be two separate businesses.

The transaction is the third largest European PE-backed buyout recorded since 2007, according to Unquote Data, and the second largest ever recorded in Benelux, behind Intelsat.

Company
Headquartered in Amsterdam, AkzoNobel's speciality chemicals division makes an array of chemical building blocks ranging from chlorine and salt to ingredients for soap and pesticides. According to press reports, Akzo Specialty Chemicals posts an annual turnover of €5bn and employs a workforce of 12,000.

People
AkzoNobel – Thierry Vanlancker (CEO).
The Carlyle Group – Martin Sumner, Zeina Bain (managing directors).  
AkzoNobel Specialty Chemicals – Werner Fuhrmann (CEO).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Benelux
  • Industrials
  • Netherlands
  • Carlyle Group

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013